• Journal of Diabetes, Endocrinology & Metabolic Disorders




Aim & Scope


The Journal of Diabetes, Endocrinology, and Metabolic Disorders (JDEMD) is a peer-reviewed, open-access journal dedicated to advancing research in diabetes, endocrinology, and metabolic diseases. Our mission is to provide a platform for high-quality research that addresses the challenges of understanding, diagnosing, and treating these complex conditions.


We publish original research, reviews, clinical studies, and expert opinions on a wide range of topics, including diabetes management, endocrine disorders, metabolic syndrome, obesity, insulin resistance, thyroid disorders, hormonal imbalances, and innovative therapies. We also focus on emerging technologies, personalized medicine, and regenerative treatments.


Our journal fosters collaboration between researchers, clinicians, and healthcare professionals, aiming to bridge the gap between scientific discoveries and clinical practice. By offering open access, we ensure the rapid dissemination of valuable knowledge, ultimately improving patient care, advancing treatment options, and promoting global health in the fields of diabetes, endocrinology, and metabolic health.


Frequency of Publication: Quarterly

Language of Publication: English

Format of the Publication: Online

Establishment of the Journal: 2025

Research Topics
OPEN FOR
SUBMISSION 100

Diabetes

Endocrinology

Metabolic Disorders

Type 1 and Type 2 Diabetes

Insulin resistance

Glucose metabolism

Glycemic control

Diabetes management

Hyperglycemia

Diabetic complications

Insulin therapy

Continuous glucose monitoring

Diabetic neuropathy

Diabetic retinopathy

Beta-cell dysfunction

Glucagon-like peptide-1 (GLP-1)

Insulin secretion

Hormonal regulation

Thyroid disorders

Hypothyroidism

Hyperthyroidism

Pituitary disorders

Adrenal insufficiency

Endocrine glands

Cortisol imbalance

Polycystic ovary syndrome (PCOS)

Reproductive hormones

Growth hormone deficiency

Testosterone deficiency

Endocrine disruptors

Endocrine disruptors

Calcium and bone metabolism

Dyslipidemia

Insulin resistance syndrome

Non-alcoholic fatty liver disease (NAFLD)

Atherosclerosis

Hyperlipidemia

Leptin resistance

Hyperinsulinemia

Mitochondrial dysfunction

Fatty acid metabolism

Lipotoxicity

Inflammation and metabolism

Metabolic adaptation

Metabolic adaptation

Cardiometabolic risk

Gut microbiota and metabolism

Insulin sensitivity

Metabolic health

Genetic predisposition

Hormone replacement therapy

Clinical trials

drug metabolism

metabolic syndrome

clinical endocrinology

pharmacokinetics

bone metabolism

preclinical pharmacology

diabetic

metabolic disease

endocrine dysfunction

meta-analyses

endocrine disease

diabetology

clinical medicine

drug tolerability

endocrine disease

exercise

obesity

drug safety

endocrine tumors

metabolism

obese

therapeutics

genetics

interventions

hormones

hormone therapy

diet

dietary

therapies

oncology

pediatrics and Nanatology

thyroid

adrenal

pituitary

parathyroid

testis

ovary

estrogen

testosterone

corticosteroids

growth hormone

prolactin

vitamin D

bone and mineral

osteoporosis

clinical pharmacology

experimental pharmacology

lipid metabolism

Editorial Board

ON BOARD
EDITORS 0